StonvexLoading…
StonvexStonvexStonvexCore line items from CDW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $22.42B | $21.00B | $21.38B | $23.75B |
Operating Income | $1.66B | $1.65B | $1.68B | $1.74B |
Net Income | $1.07B | $1.08B | $1.10B | $1.11B |
EPS (Diluted) | $8.08 | $7.97 | $8.10 | $8.13 |
Total Assets | $16.03B | $14.68B | $13.28B | $13.13B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $618.70M | $503.50M | $588.70M | $315.20M |
Free Cash Flow OCF − CapEx | $1.09B | $1.15B | $1.45B | $1.21B |
Shares Outstanding | 129.40M | 132.60M | 134.10M | 135.50M |